Form 8-K - Current report:
SEC Accession No. 0001193125-25-124527
Filing Date
2025-05-22
Accepted
2025-05-22 07:01:31
Documents
12
Period of Report
2025-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d94394d8k.htm   iXBRL 8-K 47344
  Complete submission text file 0001193125-25-124527.txt   158067

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrus-20250521.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20250521_lab.xml EX-101.LAB 17168
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20250521_pre.xml EX-101.PRE 10783
14 EXTRACTED XBRL INSTANCE DOCUMENT d94394d8k_htm.xml XML 3560
Mailing Address YALELAAN 62 3584 CM UTRECHT DE
Business Address YALELAAN 62 3584 CM UTRECHT DE 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 25974710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)